DocDollars

Ferring Pharmaceuticals As

Denmark · Reporting entity ID 100000005373

Total reported 2019–2025
$9.66M
#499 of 2,960 reporting companies — 0% of all reported industry payments
$510K in general payments across 353 records, plus $9.15M in research funding across 1,486 records.

How it breaks down

General payments $509,670
Research funding $9,153,429

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ferring Pharmaceuticals As reported $9.66M to US doctors and teaching hospitals from 2019 to 2025, ranking #499 of 2,960 reporting companies. 95% of that was research funding and 5% general payments such as consulting, speaking, food and travel. 353 general payment records and 1,486 research records were filed.

Common questions about Ferring Pharmaceuticals As

How much has Ferring Pharmaceuticals As paid US doctors?

Ferring Pharmaceuticals As reported $9,663,099 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $509,670 in general payments, $9,153,429 in research funding.

How does Ferring Pharmaceuticals As rank among drug and device companies?

It ranks #499 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ferring Pharmaceuticals As mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.